semaglutide amino acids Development of an orally delivered GLP-1 receptor agonist through peptide engineering and drug delivery to treat chronic disease Oral Treatment of Obesity by

It is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist, which enhances insulin sensitivity and regulates appetite signals in the brain

So I think time will tell in terms of the the longer term impacts

Proper nutrition and exercise can actually do wonders to support your depression and anxiety treatment

Introduction In recent years, GLP-1 receptor agonists (GLP-1RAs) have emerged as significant therapeutic options for managing type 2 diabetes and obesity

However, our body naturally produces GLP-1 and there are dietary strategies that can enhance this production